Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Teva
QuintilesIMS
Federal Trade Commission
Novartis
Johnson and Johnson
Chinese Patent Office
Cipla
Dow
Deloitte

Generated: January 24, 2018

DrugPatentWatch Database Preview

SECTRAL Drug Profile

« Back to Dashboard

When do Sectral patents expire, and what generic alternatives are available?

Sectral is a drug marketed by Promius Pharma and is included in one NDA.

The generic ingredient in SECTRAL is acebutolol hydrochloride. There are nine drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the acebutolol hydrochloride profile page.

US Patents and Regulatory Information for SECTRAL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Promius Pharma SECTRAL acebutolol hydrochloride CAPSULE;ORAL 018917-001 Dec 28, 1984 AB RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Promius Pharma SECTRAL acebutolol hydrochloride CAPSULE;ORAL 018917-003 Dec 28, 1984 AB RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for SECTRAL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Promius Pharma SECTRAL acebutolol hydrochloride CAPSULE;ORAL 018917-001 Dec 28, 1984 ➤ Subscribe ➤ Subscribe
Promius Pharma SECTRAL acebutolol hydrochloride CAPSULE;ORAL 018917-001 Dec 28, 1984 ➤ Subscribe ➤ Subscribe
Promius Pharma SECTRAL acebutolol hydrochloride CAPSULE;ORAL 018917-003 Dec 28, 1984 ➤ Subscribe ➤ Subscribe
Promius Pharma SECTRAL acebutolol hydrochloride CAPSULE;ORAL 018917-003 Dec 28, 1984 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
AstraZeneca
Cantor Fitzgerald
Fish and Richardson
Colorcon
Express Scripts
Argus Health
McKesson
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot